Fate Therapeutics Inc.
FATE | NASDAQ
$2.59
+$0.06 (+2.37%)
Sep 22, 2026, 11:18 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.85 | -1.01 | -2.28 | -3.47 | -26.12 | -43.30 |
PEG Ratio | 0.03 | n/a | 0.05 | -0.12 | -3.92 | -0.92 |
PS Ratio | 17.56 | 13.76 | 5.79 | 10.15 | 99.27 | 238.32 |
PB Ratio | 0.56 | 0.59 | 1 | 2.02 | 8.17 | 19.49 |
P/FCF Ratio | -1.04 | -1.52 | -2.66 | -3.44 | -25.96 | -169.64 |
P/OCF Ratio | -1.10 | -1.53 | -2.78 | -3.94 | -34.04 | -190.96 |
OCF/S Ratio | -1.6K | -901.43 | -208.18 | -257.74 | -291.64 | -124.80 |
Debt / Equity Ratio | 0.38 | 0.27 | 0.28 | 0.23 | 0.17 | 0.25 |
Quick Ratio | 5.79 | 7.58 | 8.48 | 4.40 | 7.79 | 5.78 |
Current Ratio | 5.79 | 7.58 | 8.48 | 4.40 | 7.79 | 5.78 |
Asset Turnover | 0.02 | 0.03 | 0.13 | 0.14 | 0.06 | 0.05 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -65.79% | -58.44% | -43.68% | -58.21% | -31.25% | -45.10% |
Return on Assets | -42.74% | -42.27% | -31.79% | -39.93% | -23.02% | -27.86% |
Return on Invested Capital | -51.39% | -51.34% | -40.25% | -51.64% | -25.66% | -23.71% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -94.12% | -769.57% | -147.41% | 85.71% | 89.52% | -299.64% |
Net Profit Margin | -2.05K% | -1.37K% | -253.30% | -292.55% | -379.89% | -551.59% |
Pretax Profit Margin | -2.05K% | -1.37K% | -253.30% | -292.55% | -379.89% | -551.59% |
Operating Profit Margin | -2.22K% | -1.54K% | -299.86% | -320.23% | -388.56% | -407.47% |
FCF Margin | -1.69K% | -906.79% | -217.86% | -294.68% | -382.43% | -140.49% |
EBITDA Margin | -1.91K% | -1.3K% | -224.52% | -278.26% | -369.41% | -397.65% |
Add to Watchlist
Select watchlists to add or remove FATE